Proteinase K Global Market Report 2023 – By Form (Lyophilized Powder Form, Liquid Form), By Therapeutic Area (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Neurology, Other Therapeutic Areas), By Application (Isolation And Purification Of Genomic DNA And RNA, In Situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End-Use (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories) – Market Size, Trends, And Global Forecast 2023-2032

Bioengineered protein drugs are defined as drugs that are manufactured through certain laboratory techniques using living cells, which include applications of biological processes and protein molecules. The use of bioengineered proteins allows for the tuning of mechanical and stimuli sensitive qualities, together with high purity and uniform molecular weight, avoiding adverse results. The main types of bioengineered protein drugs are recombinant proteins, vaccines, peptide antibiotics, therapeutic enzymes, and others. Recombinant proteins refer to proteins that are produced through genetic engineering techniques that involve inserting a gene or genes encoding a desired protein into an organism, such as bacteria or yeast. They are produced with various technologies, including bioreactors, microbial cell fermentation, fractionation, genetically modified organisms, genetic engineering, pharmacology, cell culture, microbial cell fermentation, and others, used by pharmaceutical companies, contract research organizations, research institutes, and biotechnology companies. It is used to treat various diseases, including autoimmune, heart, congenital, infectious, cancer, diabetes, arthritis, and others. The global bioengineered protein drugs market is segmented - 1) By Drug Type: Recombinant Protein, Vaccine, Peptide Antibiotics, Therapeutic Enzymes, Other Drug Type 2) By Technology: Bioreactors, Fractionation, Genetically Modified Organisms, Genetic Engineering, Pharming, Cell Culture, Microbial Cell Fermentation, Other Technology 3) By Application: Autoimmune, Heart, Congenital, Infectious Diseases, Cancer, Diabetes, Arthritis, Other Application 4) By End User: Pharmaceutical, Contract Research Organizations, Research Institutes, Biotechnology Companies The global bioengineered protein drugs market size is expected to grow from $349.20 billion in 2022 to $379.36 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global bioengineered protein drugs market size is expected to reach $514.17 billion in 2027 at a CAGR of 7.9%. The increasing prevalence of chronic disease is expected to propel the growth of the bioengineered protein drug market going forward. Chronic diseases refer to those diseases from which people suffer for a year or longer, require continuous medical care, and restrict everyday physical activities. Bioengineered protein drugs are used for the treatment of chronic diseases with designer protein therapies for use in oncology and regenerative medicine using combinatorial and logical methodologies. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of those caused by noncommunicable diseases (NCDs) or chronic diseases every year globally were 17.9 million deaths are from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths are from diabetes. Therefore, increasing chronic disease is driving the growth of bioengineered protein drugs. Major players in the bioengineered protein drugs market are Abbvie Inc., Amgen Inc., AstraZeneca PLC, Bayer HealthCare Pharmaceuticals LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, GSK PLC, Johnson & Johnson, Novartis AG, Novo Nordisk A/S, Sanofi S.A., Grifols S.A., AstraZeneca PLC, Adma Biologics Inc., CSL Limited, and Grifols S.A. Technological innovations are a key trend gaining popularity in the bioengineered protein drug market. Companies operating in the bioengineered protein drug market are adopting new technologies to sustain their position in the market. For instance, in July 2021, Janssen Pharmaceuticals, Inc., a Belgium-based pharmaceutical company, launched RYBREVANT, a Food and Drug Administration (FDA)-approved bioengineered protein drug. Rybrevant (amivantamab-vmjw) is a monoclonal antibody drug that is used to treat non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations. The technology used in the development of Rybrevant is a combination of molecular biology, cell culture, and protein engineering techniques. Rybrevant was developed using a phage display process, in which a library of antibodies is screened for those that bind specifically to the target protein. In May 2020, AbbVie Inc., a US-based pharmaceutical company, acquired Allergan for $63 billion. This acquisition expands, diversifies, and enhances AbbVie's portfolio by acquiring long-term brands in a variety of desirable therapeutic fields, such as immunology and neuroscience. Allergan Plc is an Ireland-based pharmaceutical company that is involved in the development and production of bioengineered protein drugs. North America was the largest region in the bioengineered protein drugs market in 2022. The regions covered in the global bioengineered protein drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioengineered protein drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The bioengineered protein drugs market consists of sales of cytokines, peptide antibiotics, monoclonal antibodies, replacement proteins and blood products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The bioengineered protein drugs market research report is one of a series of new reports from The Business Research Company that provides bioengineered protein drugs market statistics, including global market size, regional shares, competitors with a bioengineered protein drugs market share, detailed bioengineered protein drugs market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineered protein drugs industry. This bioengineered protein drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Protein expression is a process in which proteins are synthesized, modified, regulated, and controlled in living organisms according to the host cell. Protein expression in the context of protein research can now also refer to the application of lab procedures necessary for protein production. The main product types for protein expression are reagents, competent cells, expression vectors, services, and instruments. A reagent is a substance or compound that is added to a system in order to produce a chemical reaction or to determine whether or not a reaction occurred. The various forms of protein expression include yeast expression, mammalian expression, algae expression, insect expression, bacterial expression, and cell-free expression that are used for therapeutic, industrial, and research applications. The different end users involve pharmaceutical and biotechnology companies, academic research, and contract research organizations. The global protein expression market is segmented - 1) By Protein Expression: Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression 2) By End Use: Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations 3) By Product: Reagents, Competent Cells, Expression vectors, Services, Instruments 4) By Application: Therapeutic, Industrial, Research The global protein expression market size will grow from $2.87 billion in 2022 to $3.19 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global protein expression is expected to grow to $4.96 billion in 2027 at a CAGR of 11.6%. An increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023. Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs, Promega Corporation, Qiagen, Takara Bio, Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd., Accelagen Inc., Geneva Biotech, Viva Biotech, Becton, Dickinson & Company, Sengenics, ARTES Biotechnology GmbH, Addgene Inc., Profacgen, ProteoGenix, Peak Proteins Ltd., Domainex Ltd., Jena Bioscience GmbH, EMD Millipore, and Oxford Expression Technologies Ltd. Government regulations related to protein therapeutics and the production of biologics may hinder the protein expression market growth. Government regulations on biologics to undergo rigorous preclinical and clinical trials prior to regulatory approval, and time-consuming process for approval of biologics with regards to health and the safety of any individual are restraining the market growth. Marketing and distribution of biologics including insulin, hormones, therapeutic antibodies, and vaccines depends upon the successful completion of clinical trials, which is a long, expensive, and uncertain process. According to FDA, for an approval of new biologic, Under the regulations (21 CFR 314.81(b)(2)(vii) and 601.70, a clinical trial approval usually takes 10- 12 months where firms are required to submit a report annually on the status of clinical safety, clinical efficiency, clinical pharmacology, and nonclinical toxicology study. Companies in the industry are increasingly adopting Microfluidics technology to enhance protein expression tests in order to reduce the time, cost, labor, and increase in the accuracy and performance. The microfluidics technology effectively analyzes biological samples than the traditional (macroscale) instruments. Microfluidics technology is used to measure the expression of proteins on cells and optimizes the output to generate results regarding protein expression. Therapeutics-on-a-chip (TOC) uses microfluidic platform and is able to synthesize proteins in a point-of-care setting to reduce cost associated with storage and transportation of therapeutic proteins. For instance, companies such as MissionBio, NanoCellect Biomedical, RainDance Technologies and Sphere fluidics have implemented this technology in protein expression test. The Protein Expression market in the U.S. is governed by the Food and Drug Administration (FDA) which lays down a series of guidelines for the manufacturers and retailers of this industry. Within FDA, Centre for Drug Evaluation and research (CDER) regulates biological products under FDA 101 which includes gene therapy products and vaccines. These regulations ensure the quality, safety, and efficacy of biological therapeutics products, and speed up innovations that make these products safer, and effective. The US FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. FDA also removed a rule (Section 610.21 of the FDA code) that specified minimal potency limits for certain antibodies and antigens. The European Medicines Agency has also introduced policies that include a provision to waive the scientific advice fee, which encourages more academic groups and small companies to propose candidates for biologics. North America was the largest region in the protein expression market in 2022. Western Europe was the second largest region in the global protein expression market share. The regions covered in the global protein expression market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The protein expression market includes revenue earned by instruments, expression kits, and systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein expression market research report is one of a series of new reports from The Business Research Company that provides protein expression market statistics, including protein expression industry global market size, regional shares, competitors with a protein expression market share, detailed protein expression market segments, market trends and opportunities, and any further data you may need to thrive in the protein expression industry. This protein expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein bars are healthy snacks that comprises of plant-based or milk-derived proteins such as hemp, whey, pea, or rice protein. Protein bars includes 2:1 carbohydrate-to-protein ratio for energy and recuperation. Protein bars provide instant energy, that is needed after hectic activity. The main type of source of protein bars include plant based and animal based. Plant based protein is a useful protein supply derived from crops such as pulses, tofu, soy, nuts, certain cereals. Plant-based protein has several advantages, including higher fiber consumption, a reduced chance of heart disease and some forms of cancer, and weight management benefits. The various product forms are gluten-free protein bars, vegetarian protein bars, sports nutrition bars, others, that has different protein content type such as low protein content, medium protein content, high protein content. It is consumed by adult male, adult female, and others. The global protein bar market is segmented - 1) By Source: Plant-Based, Animal-Based 2) By Product: Gluten-Free Protein Bars, Vegetarian Protein Bars, Sports Nutrition Bars, Other Products 3) By Protein Content: Low Protein Content, Medium Protein Content, High Protein Content 4) By End-User: Adult Male, Adult Female, Other End-User The global protein bar market size is expected to grow from $3.93 billion in 2022 to $4.22 billion in 2023 at a compound annual growth rate (CAGR) of 7.31%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The global protein bar market size is expected to reach $5.53 billion in 2027 at a CAGR of 7.04%. The increasing popularity of protein-based diets is expected to propel the growth of the protein bar market going forward. Protein-based diets consist of foods that contain high amounts of protein, like meat, eggs, milk, nuts, beans, seafood, and vegan products like soy. The increased protein-based diets demand boosts the protein bar market as they are sources of proteins and other vital nutrients. For instance, in June 2022, according to the Canada National Statistical Agency, a Canada-based federal agency that offers important facts about the economy, society, and environmental issues, poultry meat sales climbed for the seventh year in a row, rising 14.9% from the previous year to $3.7 billion. Similarly, Canada produced 848.2 million dozen eggs in 2021, an increase of 1.1% annually. Since the last decade, the production of eggs in Canada has been rising year over year. Therefore, the increasing popularity of protein-based diets is driving the protein bar market. Major players in the protein bar market are General Mills Inc., The Simply Good Foods Company, Caveman Foods LLC, Kellogg Co., Glanbia PLC, Mars Incorporated, Mondelez International, Premier Nutrition Company LLC., Amway, Nestlé S.A, GNC Holdings LLC, Hormel Foods Corporation, The Bountiful Company, NuGo Nutrition, Orgain Inc., Abbott, Atkins Nutritionals Inc., Naturells India Private Limited, Post Holdings Inc., Natural Balance Foods, Nature's Bounty, Small Planet Foods Inc., and The WhiteWave Foods Company. Product innovation is the key trend gaining popularity in the protein bar market. Major companies operating in the protein bar market are focused on developing innovative products to strengthen their position in the market. For instance, in June 2022, Kellogg Company, a US-based company that manufactures and markets protein bars, breakfast cereals, cookies, and other products, launched Protein Snack Bars through its brand Special K. The Special K Protein Snack Bars are powerful, equally tasty and filling, and include 90 calories and provide a quick boost of protein on the move without compromising on flavor. They include six grams of protein and come in two mouth-watering flavors including sweet Berry Vanilla and rich chocolaty Brownie Sundae. In December 2021, Tattooed Chef Inc., a US-based manufacturer of plant-based protein bars and plant-based products, acquired Belmont Confections Inc. for approximately $18 million. Tattooed Chef Inc. will be able to extend its product line and enter into the worldwide plant-based bar. The acquisition is consistent with Tattooed Chef's expansion strategy of producing more ambient and chilled items, freeing up more shelf space, and expanding its channel penetration beyond retail and club to provide customers with the chance to experience Tattooed Chef products at home and on the go. Belmont Confections Inc. is a US-based producer of private-label protein and health bars. North America was the largest region in the protein bar market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global protein bar market report forecast period. The regions covered in the global protein bar market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein bar market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The protein bar market consists of sales of low-sugar protein bars, chocolate protein bars, peanut butter protein bars, collagen protein bars. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein bar market research report is one of a series of new reports from The Business Research Company that provides protein bar market statistics, including protein bar industry global market size, regional shares, competitors with a protein bar market share, detailed protein bar market segments, market trends and opportunities, and any further data you may need to thrive in the protein bar industry. This protein bar market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fungal protein refers to the food-grade protein ingredient made from a type of fungus for human consumption. Fungal protein is used to substitute traditional protein sources such as meat in the food industry. The major types of fungal proteins are fusarium venenatum extract, mushrooms, and yeast extract. Fusarium venenatum refers to a protein-rich microfungus belonging to the genus Fusarium. It includes organic and conventional nature. Major applications include food and beverages, bakery, processed food, dairy, and others. The global fungal protein market is segmented - 1) By Type: Fusarium Venenatum Extract, Mushrooms, Yeast Extract 2) By Nature: Organic, Conventional 3) By Application: Food and Beverages, Bakery, Processed Food, Dairy, Other Applications The global fungal protein market size is expected to grow from $3.56 billion in 2022 to $3.81 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global fungal protein market size is expected to grow to $4.87 billion in 2027 at a CAGR of 6.4%. The rising consumption of processed foods is significantly contributing to the growth of the fungal protein market going forward. Processed food refers to a food item that has gone through several mechanical or chemical processes in order to change or preserve it. Fungal protein is used as a substitute for meat and other forms of protein in processed foods due to it being significantly less polluting and sustainable than protein from livestock. For instance, in December 2021, according to the Agricultural and Processed Food Products Export Development Authority (APEDA), an India-based apex-export trade promotion active government body, India's exports of agricultural and processed food goods increased by more than 13% in the first eight months of the current fiscal, despite logistical difficulties brought on by the COVID-19 pandemic. From April through November 2020–21 to April through November 2021–22, exports of goods covered by the APEDA scope grew from $11,671 million to $13,261 million. Therefore, the rising consumption of processed food will drive the fungal protein market. Major players in the fungal protein market are Cayman Chemical Company, Chiron Biotechnology Co. Ltd., Duke Thomson's India Pvt. Ltd., DuPont de Nemours Inc., Merck Group, Royal DSM, Santa Cruz Biotechnology Inc., Siveele B.V., Halcyon Proteins Pty. Ltd., Kerry Group Plc., Lallemand Inc., Lesaffre Group, AngelYeast Co. Ltd., Associated British Foods Plc., and Koninklijke DSM N.V. Innovation is a key trend gaining popularity in the fungal protein market. Major companies operating in the fungal protein market are focusing on developing innovative solutions and new ways of working with myco-proteins to gain a competitive edge in the market. For instance, in September 2021, Novozymes A/S, a Denmark-based biotechnology company, launched Myco-protein Innovation Call, a global myco-protein innovation platform created to aid in the scaling up of innovative methods for using fungi as a source of protein. Using the power of fungi and mycelium, this global platform aims to change the way that food is produced in the future. Myco-protein Innovation Call brings together the most cutting-edge scientific and business skills from across industries and sectors in order to revolutionize the global food systems at scale. In July 2021, Ginkgo Bioworks, a US-based biotechnology company, acquired Dutch DNA Biotech B.V. for an undisclosed amount. The acquisition expands Ginkgo Bioworks’ portfolio to include fungal strain assets for the large-scale production of proteins. Dutch DNA Biotech B.V. is a Netherlands-based biotechnology company that develops fungal strains and fermentation processes for the production of proteins. Europe was the largest region in the fungal protein market in 2022. The regions covered in the global fungal protein market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the fungal protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The fungal protein market consists of sales of mycoproteins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The fungal protein market research report is one of a series of new reports from The Business Research Company that provides fungal protein market statistics, including fungal protein industry global market size, regional shares, competitors with a fungal protein market share, detailed fungal protein market segments, market trends and opportunities, and any further data you may need to thrive in the fungal protein industry. This fungal protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein labelling refers to the process of detecting or purifying the labelled protein and its binding partners by using the proper molecular labels. Most biological research uses one of three basic categories of protein labels: biotin, enzyme conjugates, or fluorescence probes. The main types of products in protein labelling are reagents, proteins, enzymes, probes or tags, and monoclonal antibodies. Monoclonal antibodies are created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. The different labelling methods include in-vitro labeling, and in-vivo labelling and are used in cell-based assays, fluorescence microscopy, immunological techniques, mass spectrometry, and protein microassays. The global protein labelling market is segmented - 1) By Product: Reagents, Protein, Enzymes, Probes/ Tags, Monoclonal Antibodies 2) By Labeling Method: In-vitro Labeling, In-vivo Labeling 3) By Application: Cell Based-Assay, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Micro Assay The global protein labelling market size will grow from $2.13 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global protein labelling is expected to grow from $3.49 billion in 2027 at a CAGR of 10.4%. Increased spending on the R&D of proteomics and genomics is driving the growth of the protein labelling reagents market. Proteomics is the study of the overall protein content of a cell, tissue, or organism. Protein labelling methods before separation and analysis are essential during proteomic profiling approaches. For instance, the National Institutes of Health (NIH) of the United States, funded $37 billion for biomedical research. This funding is for life sciences research that supports study at a molecular level for the understanding of fundamental processes by which diseases develop, the identification of biomarkers that signal the presence of disease, or identification of genes or proteins responsible for the disease. The Novo Nordisk Foundation granted a grant of up to $1.5 million to the University of Copenhagen to establish a mass spectrometry facility, which marks a new and exciting step in protein research. Therefore, the increased spending on research and development of proteomics and genomics is driving the market. Major players in the protein labelling market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer, Inc., General Electric Company, F. Hoffmann-La Roche AG, AGILENT TECHNOLOGIES INC., BIO-RAD LABORATORIES, Kirkegaard & Perry Laboratories, LI-COR Inc. and Kaneka Corporation. Drawbacks related to protein labelling techniques are expected to hinder the market. Label-free techniques are preferred over labelled techniques because of the drawbacks associated with them, such as wet-lab complexity and flexibility. While label-free samples can be measured without much preparation, wet lab pre-treatment is required for all labelling techniques. Samples must be labelled with metabolic (e.g. SILAC) or chemical (e.g. iTRAQ or TMT) reagents and the different conditions has to be combined. Therefore, label-free techniques are less prone to wet lab errors than labelling techniques. Label-free approaches have the advantage of being highly adaptable, even after the study has begun. New samples can be included at any time, but labelled approaches require the same number (n) of each condition. New samples may not be included in the study if they cannot be physically mixed and measured with the control. Labeled techniques such as the Super-SILAC approach reduce this problem but must also be carefully planned. These disadvantages are making label-free techniques preferable. Therefore, drawbacks associated with protein labeling techniques are expected to hinder the market. Companies in the protein labelling market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated as well as academic and research institutions in this market by way of partnerships, in or out-licensing deals, this trend has been increasing over recent years. For instance, recombinant protein manufacturer enGenes Biotech GmbH (enGenes) announced a collaboration with ACIB GmbH for protein labeling. In January 2020, Abcam, a UK-based protein research tools producer and seller, announced its decision to acquire Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences. Expedeon technology supports a diverse set of labels, including enzymes, metals, oligos, and fluorescent proteins. Abcam will combine the newly acquired capture and conjugation technologies with its extensive antibody and protein expertise to expand and enhance its portfolio of off-the-shelf, and custom reagents and tools. Expedeon is a Germany-based manufacturer of protein discovery and analysis products used for protein and drug research. North America was the largest region in the protein labeling market in 2022. The regions covered in the global protein labelling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein labelling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The protein labeling market includes revenues earned by entities by detecting or purifying the labelled protein and its binding partners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The protein labelling market research report is one of a series of new reports from The Business Research Company that provides protein labelling market statistics, including the industry's global market size, regional shares, competitors with a protein labelling market share, detailed protein labelling market segments, market trends and opportunities, and any further data you may need to thrive in the protein labelling industry. This protein labelling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Egg protein powder is a product made from pasteurized isolated protein from eggs.Egg protein powder has a high biological value and contains various vitamins and minerals, making it a great choice of protein powder for many people. Egg protein powder is a natural, unflavored product that has a harsh taste. Egg protein powder is mainly used because it is lactose-free and very low in carbohydrates and fats. The main types of egg protein powder are whole egg powder, egg yolk powder, and egg white powder. The whole egg powder is a dried form of the complete egg. Whole egg powder is commonly used as a substitute for protein-rich foods due to its longer shelf life when compared with fresh eggs. It includes both solid and liquid forms that are used in dietary supplements, bakery products, meat products, ice creams, and others. The global egg protein powder market is segmented - 1) By Type: Whole Egg Powder, Egg Yolk Powder, Egg White Powder 2) By Form: Solid, Liquid 3) By Application: Dietary Supplements, Bakery Products, Meat Products, Ice Creams, Other Applications The global egg protein powder market size grew from $4.33 billion in 2022 to $4.61 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The egg protein powder market size is expected to grow to $5.97 billion in 2027 at a CAGR of 6.6%. The high growth in the nutraceuticals & dietary supplement industry is expected to propel the growth of the egg protein powder market. The egg protein powder is used as a dietary supplement as it is lactose-free and has high bioavailability. It helps in improving muscle recovery, as the egg protein powder has a low content of carbohydrates and fats. Nutraceuticals are products that provide medical or health benefits. The egg protein powder market is used in nutraceuticals due to its nutritional and functional properties. The growth of the nutraceuticals & dietary supplement industry will result in the demand for egg protein powder as it is an essential dietary and nutritional supplement. For instance, according to a news release by the Food Safety and Standards Authority of India (FSSAI) in June 2021, the Indian nutraceutical market will grow to around $18 billion by 2025 whereas the Indian dietary supplements market is worth $3,924.44 million in 2020 and expected to reach $10,198.57 million by 2026 at a year on year rate of 22%. Therefore, high growth in the nutraceuticals & dietary supplement industry will drive the growth of the egg protein powder market. Major players in the egg protein powder market are Avangardco, Bouwhuis Enthoven, BNL Food Group, DEB EL FOOD, Eurovo Group, GF Ovodry, Kewpie, Post Holdings, Rose Acre Farms, Sanovo, Rembrandt, Taiyo Kagaku, DEPS, IGRECA, NOW Foods, Sharrets Nutritions LLP, and Taj Agro Products. Innovation and new product launches are key trends gaining popularity in the egg protein powder market. Key players are focusing on innovating, developing, and launching new products such as plant-based egg protein powder market that is enhanced with additional benefits for consumers such as vegan-friendly, cholesterol/fat-free, and protein benefits. Innovation and new product launches help companies to offer unique products and attract customers while gaining a competitive edge in the market. For instance, in October 2021, The EVERY Company, an American biotechnology company launched the EVERY ClearEgg, an animal-free egg white protein powder. It is marketed as the first animal-free egg white protein. The product which is in powder form can be solubilized or included in a company’s existing product. In addition, in January 2020, Noblegen Inc., a Canadian advanced nutritional ingredient company launched a plant-based whole egg powder, its first direct-to-consumer facing product. The product is vegan, and cholesterol-free offering 6g of plant-based protein per serving, which is equal to that of nature’s egg. In January 2022, Symrise AG, a German-based company producing flavoring and food ingredients signed a purchase agreement to acquire Schaffelaarbos, for an undisclosed amount. The acquisition helps Symrise to become a reference global player in pet nutritional solutions and further expand its global presence while taking an immediate leading position in the European egg protein market. Schaffelaarbos BV is a Netherlands-based producer and supplier of egg powder for human consumption, egg powder for animal feed applications, and eggshell products. Asia-Pacific was the largest region in the egg protein powder market in 2022. The regions covered in the egg protein powder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the egg protein powder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The egg protein powder market consists of sales of protein powder, egg whey, egg white protein isolate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The egg protein powder market research report is one of a series of new reports from The Business Research Company that provides egg protein powder market statistics, including egg protein powder industry global market size, regional shares, competitors with a egg protein powder market share, detailed egg protein powder market segments, market trends and opportunities, and any further data you may need to thrive in the egg protein powder industry. This egg protein powder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein supplements refer to a nutritional supplement that contains protein and is intended to supplement the diet. A protein supplement helps in building muscle, repairing tissue, and producing enzymes and hormones. It also aids in weight loss and assists in toning of muscles for athletes. The main types of protein supplements include protein powder, protein bars, and ready-to-drink products. Protein powder refers to powdered forms of protein that are derived from plants (soybeans, peas, rice, potatoes, or hemp), eggs, or milk (casein or whey protein). Other components, such as extra sugar, artificial flavors, thickeners, vitamins, and minerals, are added to enhance the flavor and functionality of the powder. Based on raw material, the protein supplements are differentiated by casein protein supplements, whey protein supplements, egg protein supplements, MPC protein supplements, and soy protein supplements. The animal-derived and plant-derived protein supplements are sold through supermarkets, hypermarkets, online stores, and drug stores. The global protein supplements market is segmented - 1) By Type: Protein Powder, Protein Bar, Ready to Drink 2) By Source: Plant-based, Animal-based 3) By Raw Material: Casein Protein Supplements, Whey Protein Supplements, Egg Protein Supplements, MPC Protein Supplements, Soy Protein Supplements 4) By Distribution Channel: Supermarkets & Hypermarkets, Online Stores, Drug Stores The global protein supplements market size grew from $18.75 billion in 2022 to $20.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the global protein supplements is expected to grow to $29.51 billion in 2027 at a CAGR of 9.4%. The rise in customer preference for food supplements is driving the protein supplements market. Food Supplements are intended to make up for dietary deficiencies among individuals through their regular diet. The desire to lead active and healthy lifestyles has increased participation in sports and fitness activities, driving the demand for food supplements, especially protein supplements. According to the Council for Responsible Nutrition survey 2020, a US-based trade association for ingredient suppliers and manufacturers in the dietary supplement industry, approximately 43% of supplement users have altered their supplement regimens after the pandemic, whereas 91% of these users report an increase in supplement intake, including the addition of new supplements to an existing routine (46%), the taking of the same supplements more frequently (25%), or the increasing of doses (22%). Thus, an increase in customer preference for food supplements is expected to boost the demand for protein supplements during the forecast period. Major players in the protein supplements market are GlaxoSmithKline (GSK), Glanbia PLC, ABBOTT LABORATORIES (ABBOTT), Amway Corporation, Herbalife International of America, Inc., PepsiCo, AMCO Proteins, QuestNutrition, GNC Holdings, Maker Nutrition LLC, SUPPLEFORM, Vitaco Health Limited, Garden of Life, Melaleuca Inc., Atlantic Multipower UK Limited, International Dehydrated Foods, Inc., Scitec Nutrition, and BRF. Strategic partnership is a key trend gaining popularity in the protein supplements market. The companies operating in the protein supplement sector are focusing on entering into strategic partnerships to expand their market reach and leverage each other's resources in new product development & marketing activities. In October 2021, a New Jersey-based company that creates collagen supplements entered into a partnership with Entenmann's, owed by Bimbo Bakeries USA. The partnership aims to create a new collagen protein powder with Entenmann's chocolate chip cookies as inspiration. Entenmann is a US-based company that manufactures and delivers baked goods. In February 2022, Nestle Health Sciences, a Switzerland-based provider of nutrition solutions, diagnostics devices, and drugs for specific target areas acquired a majority stake in Orgain, for an undisclosed amount. Through this, Nestle is focused on expanding its product portfolio in the plant-based protein supplement sector and enhancing its business presence in the fast-growing plant-based product sector across the globe. Orgain is a California-based provider of plant-based nutritional products. North America was the largest region in the protein supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the protein supplements market share duirng the forecast period. The regions covered in the protein supplements market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The protein supplements market consists of sales of soybean meal, essential amino acid, protein intake, proteins, amino acids, whey protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The protein supplements market research report is one of a series of new reports from The Business Research Company that provides protein supplements market statistics, including protein supplements industry global market size, regional shares, competitors with a protein supplements market share, detailed protein supplements market segments, market trends and opportunities, and any further data you may need to thrive in the protein supplements industry. This protein supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Textured pea protein is a protein supplement that is extracted from peas to create high-protein, plant-based meat substitutes. It is a naturally gluten-free and soy-free product with a pleasant taste and texture, offering it an ideal complement to popular ingredients in a variety of applications. Textured pea protein is non-GMO and has low allergenicity which makes it a great alternative to wheat and soy products. The main types of products in textured pea protein are yellow peas and green peas. Field peas, often known as yellow peas, are a type of pea that is best dried rather than eaten fresh. The peas' skin (seed coat) is a pale yellow color. The peas are a deeper yellow inside, but the color disappears when cooked. It has both organic and conventional nature and has different processing types such as dry processing, wet processing. It is implemented in various verticals such as food processing, animal feed, nutraceuticals, sports nutrition, infant nutrition, cosmetic and personal care, others. The global textured pea protein market is segmented - 1) By Product Type: Yellow Peas, Green Peas 2) By Nature: Organic, Conventional 3) By Processing Type: Dry Processing, Wet Processing 4) By End Use: Food Processing, Animal Feed, Nutraceuticals, Sports Nutrition, Infant Nutrition, Cosmetic And Personal Care, Other End-users The global textured pea protein market size grew from $0.53 billion in 2022 to $0.59 billion in 2023 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the textured pea protein market is expected to grow to $0.82 billion in 2027 at a CAGR of 8.8%. The rising consumer interest in plant-based protein is contributing to the growth of the textured pea protein market. In recent years, consumer interest in plant-based diets has increased significantly with vegan, vegetarian, and flexitarian diets becoming quite prevalent. The protein level of textured pea protein components is among the highest on the globe, with a pleasant taste and attractive texture. According to the Good Food Institute published report in 2021, a US-based non-profit organization to promote plant-based and cell-based alternatives to animal products, sales of plant-based foods increased three times more quickly than those of non-plant-based meals as compared to its previous years in the year 2021 in the US. Therefore, the rising consumer interest in plant-based proteins propels the growth of the textured pea protein market. Major players in the textured pea protein market are Roquette, Puris Foods, Burcon Nutrascience Corporation, Nisco ApS, Sotexpro, Exeller N.V., Vestkorn Milling AS, Nutri-Pea Limited, Cosucra Groupe Warcoing SA, Scoular, Axiom Foods Inc., AGT Foods, The Green Labs LLC, DuPont Nutrition & Biosciences, Shandong Jianyuan Group, and Kerry Group plc. The launch of organic pea protein isolate is an emerging trend in the textured pea protein market. Major companies operating in the textured pea protein sector are focused on introducing organic pea protein to meet the consumer demand for organic protein products. For instance, in June 2021, Roquette Freres, a France-based company operating in plant-based ingredients, announced the launch of NUTRALYS, a range of organic textured proteins from peas and fava beans. NUTRALYS provides 11 levels of textured proteins that provide a wide range of forms and textures with a neutral flavor and clean label, enabling a variety of meals that substitute meat and fish and offer the possibility to develop both tasty and organic plant-based gastronomy. In February 2020, Kerry Group, an Ireland-based food company acquired Pevesa Biotech S.A. for an undisclosed amount. This acquisition aims at strengthening Kerry Group’s position in the hydrolyzed plant protein space for specialized nutrition and expanding the company’s capacity to serve the rapidly growing organic plant protein market. Pevesa Biotech S.A. is a Spain-based company engaged in offering a range of proteins, including organic pea and rice protein and protein hydrolysates. North America was the largest region in the textured pea protein market in 2022. Europe was the second-largest market in the textured pea protein market. The regions covered in the textured pea protein market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the textured pea protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The textured pea protein market consists of sales of green peas and yellow peas. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The textured pea protein market research report is one of a series of new reports from The Business Research Company that provides textured pea protein market statistics, including textured pea protein industry global market size, regional shares, competitors with a textured pea protein market share, detailed textured pea protein market segments, market trends and opportunities, and any further data you may need to thrive in the textured pea protein industry. This textured pea protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.